About Us

/
Diatriview-76 Inj

Diatriview-76 Inj

/
Diatriview-76 Inj
Loading...

Diatriview-76 Inj

Category:
Composition: Diatrizoate Meglumine and Diatrizoate Sodium
Strength: 20 ml, 50 ml, 100 ml

 

Details:

Diatrizoate Meglumine and Diatrizoate Sodium are iodinated contrast agents used to enhance the visibility of internal structures during radiographic examinations. They work by increasing the contrast of images, aiding healthcare professionals in accurately diagnosing various conditions. ​

These compounds function by introducing iodine atoms into the body, which absorb X-rays effectively. This absorption increases the contrast between different tissues and structures in radiographic images, facilitating clearer visualization.

Loading...

Description

  • Administration:Diatriview-76 Inj is administered intravenously by a qualified healthcare professional in a clinical setting.​
  • Dosage:The specific volume and concentration depend on the type of procedure, patient’s age, weight, and renal function. The healthcare provider will determine the appropriate dosage.​
  • Preparation:Adequate hydration before and after administration is recommended to minimize the risk of renal complications. ​
  • Injection Site Reactions:Pain, swelling, or redness at the injection site.​
  • Nausea and Vomiting:Feelings of sickness or discomfort in the stomach.​
  • Flushing:Sudden warmth, redness, or tingly feeling.​
  • Dizziness:Light headedness or fainting sensations.​
  • Neurological Symptoms:Severe headache, confusion, or seizures.​

Seek immediate medical attention if any serious side effects occur.

  • Allergies:Inform your doctor of any known allergies to contrast agents or iodine.​
  • Kidney Function:Patients with impaired renal function should use this contrast agent cautiously, as it may exacerbate kidney issues.​
  • Pregnancy and Breastfeeding:Consult your healthcare provider before use, as the effects on fetal development and nursing infants are not fully established.​
  • Thyroid Disorders:Use with caution in patients with thyroid disease, as diatrizoate compounds may affect thyroid function tests.
Dosage and Administration
  • Administration: Diatriview-76 Inj is administered intravenously by a qualified healthcare professional in a clinical setting.
  • Dosage: The specific volume and concentration depend on the type of procedure, patient’s age, weight, and renal function. The healthcare provider will determine the appropriate dosage.
  • Preparation: Adequate hydration before and after administration is recommended to minimize the risk of renal complications.
  • Injection Site Reactions: Pain, swelling, or redness at the injection site.
  • Nausea and Vomiting: Feelings of sickness or discomfort in the stomach.
  • Flushing: Sudden warmth, redness, or tingly feeling.
  • Dizziness: Light headedness or fainting sensations.
  • Neurological Symptoms: Severe headache, confusion, or seizures.

Seek immediate medical attention if any serious side effects occur.

  • Allergies: Inform your doctor of any known allergies to contrast agents or iodine.
  • Kidney Function: Patients with impaired renal function should use this contrast agent cautiously, as it may exacerbate kidney issues.
  • Pregnancy and Breastfeeding: Consult your healthcare provider before use, as the effects on fetal development and nursing infants are not fully established.
  • Thyroid Disorders: Use with caution in patients with thyroid disease, as diatrizoate compounds may affect thyroid function tests.